Abiraterone Proves Efficient Against Prostate Cancer

Abiraterone Proves Efficient Against Prostate Cancer
According to two recent studies, abiraterone, a drug for prostate cancer treatment, was found to increase survival in patients with advanced prostate cancer when given before chemotherapy. These encouraging results were published in Lancet Oncology. A previous study had found that patients that took abiraterone before chemotherapy decreased cancer progression time, but did not improve overall

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , .

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

Leave a Comment

Your email address will not be published. Required fields are marked *